BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22538023)

  • 1. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use.
    Laskin DM
    J Oral Maxillofac Surg; 2012 May; 70(5):1240-2. PubMed ID: 22538023
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Tzanidakis K; Moss C; Gibbons AJ
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):97. PubMed ID: 24148698
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ; Patel AA; Amin J
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
    Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
    J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
    Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
    O'Leary M; Dierich M
    Urol Nurs; 2010; 30(4):228-34. PubMed ID: 20949807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral palsy and bruxism: Effects of botulinum toxin injections-A randomized controlled trial.
    Cahlin BJ; Lindberg C; Dahlström L
    Clin Exp Dent Res; 2019 Oct; 5(5):460-468. PubMed ID: 31687178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis.
    Galvin R; Callaghan C; Chan WS; Dimitrov BD; Fahey T
    Semin Arthritis Rheum; 2011 Jun; 40(6):585-7. PubMed ID: 21397930
    [No Abstract]   [Full Text] [Related]  

  • 17. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
    von Lindern JJ
    Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Botulinum toxin type A: an arsenal in dentistry.
    Rao LB; Sangur R; Pradeep S
    Indian J Dent Res; 2011; 22(3):440-5. PubMed ID: 22048586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of severe bruxism with botulinum toxin type A].
    Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
    Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulism toxin: use in disorders of the temporomandibular joint.
    Chang H
    Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.